Biopharma Convergence in Asia - Verticaltalk Pharma | e-Newsletter | Volume 1 No. 2 | 2006

Pharma Focus Asia - eNewsletter

Verticaltalk Pharma e-Newsletter

Volume 1 No.2 2006

Biopharma Convergence

inAsia

PFA - Issue March 2006


	China Pharma’s Cephalosporin gets GMP Certification

	Ranbaxy's agreement with Swiss company Debiopharm

	Dr. Reddy’s settlement with GSK


	Global PharmaBio Alliance 2006, Kerala, India From Nov 6 -Nov 7 '06

	China-Pharm - China International Pharmaceutical Industry Exhibition, Beijing, China From Nov 7 - Nov 10 '06

	Generics Asia 2006, Singapore From Nov 23 - Nov 24 '06

Pharma Press Releases


	Waters Corporation and Imperial College London Expand Systems Biology Collaboration

	Clinphone Conducts Educational Webinar on New FDA Guidelines

	Singapore's biomedical sector gets new boost from Korea

Current Issue \| Archives \| Advertise
In this issue of The Pharma Edge
Asia Pharmaceutical Sector Biopharma Convergence Superdisintegrant Performance Lifecycle Management Strategies	Pharmacokinetics Knowledge Accumulation India’s Clinical Research Market Pharma News

Asia Pharmaceutical Sector – Outlook by Liew Kou Yew, Assistant Vice President,
Life Sciences - Asia, Rabobank International

Given its traditional resourcefulness and determination, it is beyond doubt that Asia’s place within the global pharmaceutical industry over the next few decades will grow in rapid prominence. Asia, led by Japan and India, will start developing a robust pipeline of novel drugs that address the needs of both Asia and the rest of the developed world such as the US and Europe.

Biopharma Convergence – Is Asia ready?

Biopharma convergence is the buzzword in the global pharmaceutical industry. Pipeline pressures and funding shortfalls are compelling the pharma and biotech firms to leverage each other's complementary core competencies. However, Asia is still in the process of catching up with this trend of biopharma convergence, and industry experts have their own opinions regarding its impact on the markets in Asia. To gain more insights on the trend, The Pharma Edge invited the following experts for a debate:

John Wong, Regional Chair, Asia Pacific, Boston Consulting Group

Kiran Mazumdar-Shaw, CMD, Biocon Limited

Heather E Fraser, Global Life Sciences Lead, IBM Institute for Business Value

F M Scherer, Professor, Harvard University

Tom Newton, Pharmaceutical Market Analyst, Visiongain

Pharma Bookshelf

Knowledge Accumulation and Industry Evolution: The case of pharma-biotech
Editors: Mariana Mazzucato, Giovanni Dosi

Pharmacokinetics and Metabolism in Drug Design
Editors: Raimund Mannhold, Hugo Kubinyi, Gerd Folkers

Clinical Trials of Drugs and Biopharmaceuticals
Authors: Chi-Jen Lee, Lucia H., Christopher L. Wu, Benjamin R. Lee, Mei-Ling Chen

Research Insights

The Influence of Product Brand-to-Brand Variability on Superdisintegrant Performance -
A Case Study with Croscarmellose Sodium

The purpose of this study is to investigate factors influencing croscarmellose sodium functionality with special emphasis on developing a discriminating model tablet formulation to evaluate product brand-to-brand variability. The particle size distribution, water uptake, and swelling properties of five brands of croscarmellose sodium in either neutral water or 0.1 N HCl were studied.

Projects

TechnoTrends

Industry Reports

Lonza Group and BioOne’s Custom Biopharmaceuticals Plant, Singapore The project is scheduled for completion by the end of 2009 with an estimated investment of US$ 250 million. and will strengthen Lonza and BioOne as leading global custom manufacturers of biopharmaceuticals.

SCHOTT's Pharmaceutical Packaging Plant, China SCHOTT has become the first international manufacturer of primary pharmaceutical packaging made of glass to establish a production site in China.

Artel's MVS ADVANCED Artel’s latest laboratory innovation - MVS ADVANCED - to optimize automated liquid handlers by providing a customizable and portable device for volumetric measurements within minutes. It allows for more frequent checks ensuring greater data integrity.

Pall Corporation - GBK Containment System Pall Corporation’s Flexible Containment System is an all-in-one glove bag / housing system for filter change-out which will ensure workers’ safety in hazardous environments.

Lifecycle Management Strategies - Maximizing ROI through indication expansion, reformulation and Rx-to-OTC switching - Business Insights Maximizing ROI of brands through appropriate lifecycle management is a key objective for pharma companies as patent expiration results in steep sales declines.

A New Era Begins for India’s Clinical Research Market - Thomson CenterWatch The clinical research outsourcing market in India grew to $70.5 million last year and will continue to climb.



You are receiving this email because you are either a registered member or requested for a newsletter from Verticaltalk Pharma. To SUBSCRIBE QUESTIONS: For questions or assistance, please contact our Customer Support Staff : verticaltalkpharma@ochre-media.com PRIVACY: View our Privacy Policy Copyright © 2008 Ochre Media Private Limited. All rights reserved.